Delivery Order SPE2DB22D3009-SPE2DB25FBE47
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ondansetron HCL 8 mg tablets (30-count) with a contract ceiling value of approximately $43K. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 25, 2025. AmerisourceBergen will perform the work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) with a ceiling value of $12,954.75. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance and fulfillment location for this pharmaceutical delivery. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) with a ceiling value of $26,991.21. This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ondansetron HCl 8 mg tablets (30-count units) with a ceiling value of $2,131.22. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on September 2, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,707.67 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count packaging). This contract, awarded on August 19, 2025, with a completion date of August 20, 2025, utilizes firm fixed pricing and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 4, 2025, for Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $3,208.01. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. The order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child action under...
- The Defense Logistics Agency awarded a delivery order valued at $35,913.34 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with the contractor's corporate headquarters location. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $28,026.72 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages). This competitively awarded, firm fixed price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $29,329.04. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,373.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (500 count) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBE47Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count) with a ceiling value of $13,223.67. This delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and other critical medical commodities. AmerisourceBergen's status as a major pharmaceutical distributor and recurring federal contractor demonstrates its established capability to fulfill Defense Logistics Agency medical procurement requirements through competitive federal contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 9/4/25 |